Core Insights - Fulton Financial Corp. (FULT) has agreed to acquire Blue Foundry Bancorp (BLFY) in an all-stock transaction valued at approximately $243 million [1][7]. Transaction Details - Fulton will exchange 0.6500 shares for each share of Blue Foundry, with the merger agreement approved by the boards of both companies [2]. - The deal is expected to close in the second quarter of 2026, pending regulatory approvals and Blue Foundry's shareholder consent [3]. - Upon completion, Blue Foundry Bank will merge into Fulton Bank, N.A., and Fulton will contribute $1.5 million to the Fulton Forward Foundation for community grants in New Jersey [3]. Strategic Rationale - The acquisition accelerates Fulton's expansion in the northern New Jersey market and is projected to increase first full-year earnings by over 5% [4]. - The deal is expected to enhance tangible book value per share immediately while maintaining regulatory capital ratios at closing [4]. - Fulton aims to leverage its banking services to provide greater convenience and innovative solutions to a larger customer base, aligning with its strategy for organic growth across various business segments [5]. Market Performance - Fulton's shares have declined by 18.2% over the past year, compared to an 8.7% decline in the industry [6].

Core Insights - The deal was announced alongside Palo Alto Networks reporting higher revenue in its latest quarter [1] - The company has raised its top-line view for the year, indicating positive growth expectations [1] Financial Performance - Palo Alto Networks posted increased revenue in the latest quarter [1] - The company has adjusted its revenue outlook upwards for the year, reflecting confidence in continued growth [1]

Core Insights - Ardurra Group, Inc. has acquired MKN & Associates, a California-based firm specializing in water and wastewater engineering services, enhancing its expertise in the water sector [1][2][3] Company Overview - Ardurra is ranked 75 on Engineering News-Record's Top 500 Design Firms list and is consistently among the top 20 firms in ENR's Water Sourcebook rankings for water and wastewater [2] - MKN, founded in 2012, has grown to over 85 professionals and has successfully delivered hundreds of water and wastewater projects for municipalities and public agencies [3][8] - The acquisition strengthens Ardurra's presence in the Western U.S. and complements its existing water practice [3] Leadership Statements - Ernesto Aguilar, President and CEO of Ardurra, emphasized MKN's reputation for solving complex challenges and the potential for shared strengths through this partnership [4] - Mike Nunley, President and CEO of MKN, highlighted the opportunity to enhance their mission and serve clients and the community more effectively through the partnership with Ardurra [4] Operational Details - MKN will continue to operate from its headquarters in San Luis Obispo, California, along with seven additional offices across the state [4] - Following the acquisition, Ardurra will have a combined team of approximately 2,100 employees across more than 100 offices nationwide [4]

Sealed Air has struck a deal to be acquired by private equity firm Clayton Dubilier & Rice in an all-cash transaction with an enterprise value of $10.3 billion. ...

Core Viewpoint - Avadel Pharmaceuticals has received an unsolicited acquisition proposal from H. Lundbeck A/S, valuing Avadel at up to $23.00 per ordinary share, which translates to a total equity value of approximately $2.4 billion, representing a 29% premium over Avadel's closing price prior to the announcement of the Alkermes acquisition [3][4]. Summary by Sections Acquisition Proposal - The Lundbeck Proposal includes $21.00 per ordinary share in cash at closing and a contingent value right (CVR) that could provide additional cash payments of up to $2.00 per share based on sales milestones for LUMRYZ™ and valiloxybate by specified dates [4]. - The proposal is contingent upon various closing conditions, including shareholder approval from Avadel and necessary regulatory approvals [4]. Company Response - Avadel's Board of Directors has determined that the Lundbeck Proposal constitutes a "Company Superior Proposal" under its existing agreement with Alkermes, triggering a five business day negotiation period with Alkermes [5][6]. - During this period, Avadel will discuss any potential amendments to the Alkermes Transaction Agreement that could alter the status of the Lundbeck Proposal [5]. Current Status - The Alkermes Transaction Agreement remains in effect, and Avadel's Board has not changed its recommendation in support of the Alkermes acquisition, indicating no immediate action is required from Avadel shareholders [7]. - Avadel will refrain from further comments on the Lundbeck Proposal until the negotiation period with Alkermes concludes [8]. Financial Advisors - Morgan Stanley and Goldman Sachs are serving as financial advisors to Avadel in relation to the acquisition discussions [10][23].

Core Viewpoint - Alkermes plc acknowledges the announcement by Avadel Pharmaceuticals plc regarding a potential acquisition offer from H. Lundbeck A/S for all issued and to be issued ordinary shares of Avadel [1][2]. Group 1: Transaction Agreement Details - The Transaction Agreement stipulates that Avadel cannot terminate the agreement to pursue a superior proposal unless the board determines that doing so is consistent with its fiduciary duties and that the Lundbeck offer qualifies as a superior proposal [3]. - Avadel must notify Alkermes in writing at least five business days prior to taking any action related to the Lundbeck offer and must engage in good faith discussions with Alkermes regarding any amendments to the Transaction Agreement [3]. Group 2: Future Announcements - Alkermes will make further announcements as appropriate regarding the situation and any developments related to the potential acquisition [4].

Bagsværd, Denmark, 4 November 2025 – On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera)1. Today, Novo Nordisk confirms that it has submitted an updated, unsolicited proposal to acquire Metsera. The updated proposal has been declared superior by Metsera’s board of directors. The acquisition of Metsera, including its early and development-stage incretin and non-incretin analogue peptide programmes, would provide Novo Nordisk the opportunity ...

Core Viewpoint - Denny's is being acquired by a group of investors for $620 million, taking the breakfast chain private, with a unanimous board approval [1][2]. Group 1: Acquisition Details - Denny's shareholders will receive $6.25 per share in cash, totaling $322 million, which represents a 52% premium over the closing stock price on the day of the announcement [2]. - The acquisition is led by TriArtisan Capital Advisors, Treville Capital, and Yadav Enterprises, one of Denny's largest franchisees [1][5]. - Denny's shares surged by 47% in after-hours trading following the announcement [2]. Group 2: Company Background - Denny's was founded in 1953 and has undergone several name changes, with its current branding established in 1959 [2]. - The company began trading on the New York Stock Exchange in 1969 [2]. Group 3: Recent Challenges - Denny's experienced a significant decline in sales during the COVID pandemic and has been adapting to changing customer dining preferences, including a shift towards delivery services [3]. - The company has faced competition from newer chains offering healthier breakfast options [3]. - In response to performance issues, Denny's announced plans to close 150 of its lowest-performing locations [4]. Group 4: Future Outlook - Denny's CEO indicated that the board considered multiple offers and believes the acquisition is in the best interest of shareholders [5]. - The deal is expected to close in the first quarter of 2026, pending shareholder approval [6].

Core Viewpoint - The proposed sale of Comerica Incorporated to Fifth Third Bancorp is under investigation to assess whether the transaction adequately values Comerica and the process leading to this valuation is appropriate [1]. Summary by Relevant Sections - **Transaction Details** - Shareholders of Comerica will receive 1.8663 shares of Fifth Third for each share of Comerica they own [1]. - **Legal Investigation** - Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating the proposed sale to determine if the consideration is sufficient or if it undervalues Comerica [1][2].

Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2][3] - The news team covers key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] - Proactive specializes in medium and small-cap markets while also keeping the community updated on blue-chip companies, commodities, and broader investment stories [2][3] Group 2 - The team delivers news and insights across various sectors including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4][5] - All content published by Proactive is edited and authored by humans, ensuring adherence to best practices in content production and search engine optimization [5]